Telix Pharmaceuticals doses first US patients with FDA-approved Pixclara for glioma imaging

Telix Pharmaceuticals says the first patients in the US have been dosed with Pixclara, its FDA-approved amino acid positron emission tomography drug for glioma imaging.

Detected & updated continuously · Source: Nebula